PUBLISHER: Euromonitor International | PRODUCT CODE: 1561935
PUBLISHER: Euromonitor International | PRODUCT CODE: 1561935
Sleep Aids in France
Sales of sleep aids in France are experiencing double-digit volume and current value growth in 2024, despite the conclusion of the pandemic and its associated challenges. The rise in sales during the pandemic years of 2020-2021 was driven by heightened stress, anxiety, and insomnia, which resulted from lockdowns, remote working, home-schooling, and job security fears.
Euromonitor International's Sleep Aids in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Sleep Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
TABLE OF CONTENTS
List Of Contents And Tables
KEY DATA FINDINGS
2024 DEVELOPMENTS
- Sleep aids continues to reap benefits from consumer stress and anxiety
- Gummies gain rapid ground
- Sanofi's Novanuit remains overall leader
PROSPECTS AND OPPORTUNITIES
- Demand set to continue throughout forecast period, despite challenges ahead
- Possible new competition from other consumer health options
- Potential for expansion in sea magnesium, melatonin and CBD
CATEGORY DATA
- Table 1 Sales of Sleep Aids: Value 2019-2024
- Table 2 Sales of Sleep Aids: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Sleep Aids: % Value 2020-2024
- Table 4 LBN Brand Shares of Sleep Aids: % Value 2021-2024
- Table 5 Forecast Sales of Sleep Aids: Value 2024-2029
- Table 6 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
CONSUMER HEALTH IN FRANCE
EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 1 Research Sources
